Janus Henderson Global Life Sciences Fund Class N (JFNNX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
83.16
+0.89 (1.08%)
At close: Feb 27, 2026
Fund Assets5.40B
Expense Ratio0.68%
Min. Investment$1,000,000
Turnover30.00%
Dividend (ttm)3.77
Dividend Yield4.58%
Dividend Growth-7.44%
Payout FrequencyAnnual
Ex-Dividend DateDec 5, 2025
Previous Close82.27
YTD Return2.88%
1-Year Return22.06%
5-Year Return50.70%
52-Week Low58.81
52-Week High83.35
Beta (5Y)n/a
Holdings104
Inception DateJan 26, 2018

About JFNNX

Janus Henderson Global Life Sciences Fund is an actively managed sector equity health fund launched by Janus Henderson in 2018. Its primary function is to provide long-term capital growth by investing in companies across the life sciences sector, including biotechnology, health care services, medical devices, and pharmaceuticals. The fund aims to outperform the MSCI World Health Care Index by at least 2% per annum over five years. It invests at least 80% of its assets in equities of companies addressing unmet medical needs or improving health care efficiencies. The fund is notable for its balanced portfolio approach and is managed by an experienced team specializing in health care science and business. This asset plays a significant role in the health care investment landscape, offering a diversified portfolio that aligns with the broader health care industry.

Fund Family Janus Henderson
Category Health
Performance Rating High
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol JFNNX
Share Class Class N
Index MSCI World/Health Care NR

Performance

JFNNX had a total return of 22.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 18.10%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
JFNIXClass I0.77%
JNGLXClass D0.80%
JAGLXClass T0.92%
JFNAXClass A0.98%

Top 10 Holdings

38.87% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY9.66%
Johnson & JohnsonJNJ5.59%
AstraZeneca PLCAZN4.27%
UnitedHealth Group IncorporatedUNH3.44%
AbbVie Inc.ABBV3.39%
Abbott LaboratoriesABT2.65%
argenx SEARGX2.63%
Novartis AG ADRNVSN.MX2.50%
Praxis Precision Medicines, Inc.PRAX2.39%
Boston Scientific CorporationBSX2.35%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 5, 2025$3.76513Dec 5, 2025
Dec 6, 2024$4.06789Dec 6, 2024
Dec 7, 2023$3.00343Dec 7, 2023
Dec 20, 2022$0.27276Dec 20, 2022
Dec 20, 2021$6.91402Dec 20, 2021
Dec 17, 2020$5.65748Dec 17, 2020
Full Dividend History